Top Markets
Coin of the day
BioSig Technologies, Inc. BioSig Technologies, Inc.

BioSig Technologies, Inc.

BSGM
株式のランク #10875
BioSig Technologies, Inc., along with its subsidiaries, operates as a medical... BioSig Technologies, Inc., along with its subsidiaries, operates as a medical technology enterprise. Its core innovation is the PURE EP (precise uninterrupted real-time evaluation of electrograms electrophysiology) system. This proprietary signal processing platform, merging specialized hardware and software, tackles well-known difficulties in electrophysiological signal acquisition, empowering electrophysiologists to instantaneously view and analyze vital cardiac signals. The system further enhances the collection of intracardiac signals and diagnostic data crucial for atrial fibrillation procedures. Moreover, it is specifically engineered to overcome persistent obstacles that traditionally slow down and complicate cardiac catheter ablation. BioSig also holds a research agreement with the University of Minnesota, targeting the development of new treatments for sympathetic nervous system disorders. Additionally, it has a strategic partnership with the Mayo Foundation for Medical Education and Research, focused on creating an advanced AI and machine learning software solution tailored for its PURE EP platforms. Established in 2009, BioSig Technologies, Inc. is headquartered in Westport, Connecticut.
株価
$5.52
最終同期: 2025-10-09
時価総額
$775.10M
変化(1日)
1.28%
変化(1年)
15.48%
US
取引 BioSig Technologies, Inc. (BSGM)

カテゴリー

BioSig Technologies, Inc.(BSGM)の配当履歴
BioSig Technologies, Inc.(証券コード:BSGM)は合計で0回の配当を行いました。
すべての配当の合計(株式分割調整済み)は:0.00
配当利回り(TTM):0
2026から2026までのBioSig Technologies, Inc.(BSGM)の配当履歴
年間配当支払い
配当(株式分割調整済み) 変化
提供された日付のデータは十分ではありません。
すべての配当支払いの一覧
配当 変化
提供された日付のデータは十分ではありません。
同業他社や競合企業の配当履歴